We are live on ! Find out more
PIII icon

P3 Health Partners

33 hedge funds and large institutions have $2.9M invested in P3 Health Partners in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

0.03% less ownership

Funds ownership: 0.25%0.21% (-0.03%)

11% less funds holding

Funds holding: 3733 (-4)

37% less capital invested

Capital invested by funds: $4.57M → $2.9M (-$1.67M)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

Holders
33
Holders Change
-4
Holders Change %
-10.81%
% of All Funds
0.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
8
Reduced
7
Closed
8
Calls
Puts
Net Calls
Net Calls Change

PIII Hedge Fund Activity: Q1 2025 in Review

33 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q1 2025, worth a combined $2.9M — down 37% from $4.57M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of PIII and 4 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 8 added.

The largest buyer was Corient Private Wealth, adding an estimated $118K. The largest seller was Alyeska Investment Group, cutting an estimated $564K.

  • 33 institutional investors held P3 Health Partners (PIII) as of Q1 2025, down from 37 in Q4 2024.
  • Funds reported $2.9M of P3 Health Partners stock for Q1 2025, down 37% quarter-over-quarter.
  • 4 funds opened new P3 Health Partners positions in Q1 2025 and 8 closed out, a net change of -4 holders.
  • The largest P3 Health Partners buyer in Q1 2025 was Corient Private Wealth, an estimated $118K added.
  • The largest P3 Health Partners seller in Q1 2025 was Alyeska Investment Group, an estimated $564K sold.

Based on aggregated 13F filings for Q1 2025.